466 results on '"Thyssen, Jacob P"'
Search Results
2. Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea
3. Elevated plasma levels of calcitonin gene‐related peptide in individuals with rosacea: A cross‐sectional case–control study
4. RNA‐sequencing of paired tape‐strips and skin biopsies in atopic dermatitis reveals key differences
5. Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis
6. Fatigue is associated with disease severity in adult patients with hidradenitis suppurativa
7. The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with asthma, rhinitis, and disease severity
8. Adverse events from topical corticosteroid use in chronic hand eczema — Findings from the Danish Skin Cohort
9. Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis
10. 548 - Tralokinumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients aged 12 years and older with and without atopic comorbidities
11. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis – a cross sectional study
12. 552 - Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis
13. Impact of climate change on atopic dermatitis: A review by the International Eczema Council
14. Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study
15. Prevalence and incidence of hand eczema in healthcare workers: A systematic review and meta‐analysis
16. Higher occurrence of ocular surface disease symptoms in patients with atopic dermatitis—Data in the FOREVER study
17. Inflammatory plasma signature of chronic hand eczema: Associations with aetiological and clinical subtypes
18. Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT)
19. Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated With Improved Quality of Life Outcomes in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
20. Treat-to-Target in Atopic Dermatitis
21. Comorbidity burden in adult atopic dermatitis: A population‐based study
22. Predicting Psoriatic Arthritis in Psoriasis Patients – A Swiss Registry Study
23. No associations between type 1 diabetes and atopic dermatitis, allergic rhinitis, or asthma in childhood: a nationwide Danish case-cohort study
24. The vIGA‐AD scale for atopic dermatitis: uptake in the past five years and position of the International Eczema Council
25. Limited clinical role of blood eosinophil levels in early life atopic disease: A mother–child cohort study
26. Atopic dermatitis phenotypes based on cluster analysis of the Danish Skin Cohort
27. Comorbidities in childhood atopic dermatitis: A population‐based study
28. Treat‐to‐target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis
29. Predicting discontinuation of biologic therapy caused by adverse events in psoriasis patients—A Danish nationwide cohort study
30. Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary
31. Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial
32. Pregnancy outcomes in patients exposed to baricitinib in clinical trials and during post-marketing surveillance
33. Mapping the road to biologics in psoriasis and psoriatic arthritis: A nationwide drug utilization study
34. The Proteome of Hand Eczema Assessed by Tape Stripping
35. Contact Allergy to Metals
36. Hypersensitivity Reactions to Orthopedic Implants
37. Hand Eczema: Causative Factors, Diagnosis, Personal and Societal Consequences
38. Metals
39. Hand Eczema: Causative Factors, Diagnosis, Personal and Societal Consequences
40. Contact Allergy to Metals
41. Acute and Recurrent Vesicular Hand Dermatitis
42. Hyperkeratotic Dermatitis of the Palms
43. The association between Staphylococcus aureus colonization on cheek skin at 2 months and subsequent atopic dermatitis in a prospective birth cohort
44. A Skin Care Program to Prevent Skin Problems due to Diabetes Devices in Children and Adolescents: A Cluster-Controlled Intervention Study
45. A detailed look at the European Medicines Agency's recommendations for use of Janus kinase inhibitors in patients with atopic dermatitis
46. Similar Skin Barrier Function in Persons with Type 1 Diabetes Compared with Healthy Controls
47. Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16
48. Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
49. Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey
50. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.